✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Panacea Biotec Ltd.

PANACEABIO

Market Cap
₹3,296 Cr.
P/E
0.00

Panacea Biotec Ltd.

About
Panacea Biotec Limited is a prominent biotechnology company in India specializing in the research, development, manufacturing, and marketing of vaccines globally. The company has partnered with UN Hea… Read more
Panacea Biotec Limited is a prominent biotechnology company in India specializing in the resea… Read more
Low
112
52W Range
High
549
  • Panacea Biotec
  • Guj. Themis Biosyn
  • Gufic Biosciences
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

9 Yes

Positive for this company

0 Neutral

Neutral for this company

7 No

Negative for this company

1 No Data

Insufficient data to analyse

Market Share
0.01 %
(as of Jul 22)
Historic
Anti - Diabetes - Market Share
0.01 %
(as of Jul 22)
Historic
Anti-Infectives - Market Share
3.44 %
(as of Nov 21)
Historic
Antineo Plastic - Market Share
0.04 %
(as of Nov 21)
Historic
Blood Related - Market Share
0.01 %
(as of Jul 18)
Historic
Cardiovascular - Market Share
0.02 %
(as of Nov 21)
Historic
Endocrinology - Market Share
Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Vaccines

Location Wise Break-Up - Formulations

Location Wise Break-Up

Therapeutic Area Break-Up - India

Operating Profit Break-Up

Capex

Brand Wise Break-Up

Asset Break-Up

Operational Metrics

    locked
    Select a Metric
    • Number of ANDA's Filed in USA (.)
      Source
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Suppliers
    • Vascon Engineers Ltd.
    • Innovators Facade Systems Ltd.
    FAQs on Panacea Biotec Ltd. Business

    Panacea Biotec Limited is a prominent Indian biotechnology company specializing in vaccines. It is acknowledged by UN Health Agencies for its significant role in the Global Polio Eradication Initiative.

    Panacea Biotec major competitors are Guj. Themis Biosyn, Gufic Biosciences, Sequent Scientific, Zota Health Care, Orchid Pharma, Indoco Remedies, Novartis.
    Market Cap of Panacea Biotec is ₹3,144 Crs.
    While the median market cap of its peers are ₹3,338 Crs.

    Panacea Biotec seems to be less financially stable compared to its competitors.
    Altman Z score of Panacea Biotec is 4.49 and is ranked 5 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Jun Dec
    Investor Presentation Mar Jun Mar Dec Jun
    Conference Call
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Panacea Biotec Ltd.
    Panacea Biotec - Global Vaccine powerhouse in making ? - Cash Cow
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material